The long and difficult road to the diagnostic market: protein microarrays
- 1 November 2006
- journal article
- editorial
- Published by Elsevier in Drug Discovery Today
- Vol. 11 (21-22) , 959-961
- https://doi.org/10.1016/j.drudis.2006.09.014
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Diagnostic challenges for multiplexed protein microarraysDrug Discovery Today, 2006
- Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancerThe Journal of Pathology, 2006
- Microarray Expression Technology: From Start to FinishPharmacogenomics, 2005
- Multiplex proteomic approaches to sepsis research: case studies employing new technologiesExpert Review of Proteomics, 2005
- Development of a High-Throughput Automated Analyzer Using Biochip Array TechnologyClinical Chemistry, 2005
- Evaluation of the BioPlex™ 2200 ANA Screen: Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive AutoantibodiesAnnals of the New York Academy of Sciences, 2005
- Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseasesAutoimmunity, 2005
- Microarray technology: an increasing variety of screening tools for proteomic researchDrug Discovery Today: TARGETS, 2004
- Taking stockNature Genetics, 2002
- Multi-analyte immunoassayJournal of Pharmaceutical and Biomedical Analysis, 1989